Seven months after LabCorp’s strategic review resulted in no corporate changes, the laboratory testing and diagnostics giant announced on Thursday plans to spin out its nearly $6 billion a year ...

Labcorp is now offering a blood-based biomarker test in the U.S. to support the diagnosis ... assays and PET imaging cleared by the Food and Drug Administration. The sensitivity and specificity ...

Physicians can now use the test with patients ... In addition, Labcorp is spending on innovation and technology that supports diagnostic and drug development testing across disease areas ...

the first over-the-counter blood test granted market authorization by the U.S. Food & Drug Administration (FDA) that can be performed by both physicians and patients. Labcorp will serve as the ...

Labcorp said Wednesday it has debuted a test designed to identify the presence ... The pTau217 marker has been used in Alzheimer's drug trials to monitor patients on anti-amyloid therapy.

The new test is part of Labcorp's ongoing efforts to support healthcare ... has played a significant role in diagnostics and drug development, supporting a substantial percentage of FDA-approved ...

BURLINGTON, N.C., May 30, 2025 /PRNewswire/ -- Labcorp (NYSE ... The additions include new test offerings for solid tumor and hematologic malignancies and enhanced biopharma solutions designed ...

A few websites can be used to order this test and numerous other ... or Labcorp OnDemand (ondemand.labcorp.com). The ALPACA trial showed that the experimental drug lepodisiran can lower this ...

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood ...

April 29 (Reuters) - Laboratory operator Labcorp (LH.N), opens new tab beat ... the critical nature of the work we do in diagnostics and drug development positions us well for success in 2025 ...